MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacc.2004.06.070

Медицинская библиотека · Journal of the American College of Cardiology · 2004

A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease.

Hovingh G Kees, Brownlie Alison, Bisoendial Radjesh J, Dube Marie Pierre, Levels Johannes H M, Petersen Wilma, Dullaart Robin P F, Stroes Erik S G, Zwinderman Aeilko H, de Groot Eric, Hayden Michael R, Kuivenhoven Jan Albert, Kastelein John J P

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVES

We investigated the consequences of an apolipoprotein A-I (apoA-I) gene defect with regard to lipid metabolism, endothelial function, arterial wall thickness, and coronary artery disease (CAD) risk.

BACKGROUND

Due to limited numbers of carriers of the apoA-I defects, data on the consequences of such defects have remained inconclusive.

METHODS

Lipids and lipoproteins were measured in 54 apoA-I (L178P) carriers and 147 nonaffected siblings. Flow-mediated dilation (FMD) was assessed in 29 carriers and 45 noncarriers, and carotid intima-media thickness (IMT) could be determined in 33 heterozygotes and 40 controls. Moreover, CAD risk was evaluated for all apoA-I mutation carriers.

RESULTS

Heterozygotes exhibited lower plasma levels of apoA-I (-50%; p < 0.0001) and high-density lipoprotein cholesterol (-63%; p < 0.0001). In addition, carriers had impaired FMD (p = 0.012) and increased carotid IMT (p < 0.001), whereas multivariate analysis revealed that heterozygotes had a striking 24-fold increase in CAD risk (p = 0.003).

CONCLUSIONS

Heterozygosity for a novel apoA-I mutation underlies a detrimental lipoprotein profile that is associated with endothelial dysfunction, accelerated carotid arterial wall thickening, and severely enhanced CAD risk. Importantly, the extent of atherosclerosis in these subjects was similar to the burden of premature arterial wall abnormalities seen in patients with familial hypercholesterolemia. These data illustrate the pivotal role in humans of apoA-I in the protection against CAD.

Для цитирования: Hovingh G Kees, Brownlie Alison, Bisoendial Radjesh J, Dube Marie Pierre, Levels Johannes H M, Petersen Wilma, Dullaart Robin P F, Stroes Erik S G, Zwinderman Aeilko H, de Groot Eric, Hayden Michael R, Kuivenhoven Jan Albert, Kastelein John J P. A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease.. Journal of the American College of Cardiology. 2004. DOI: 10.1016/j.jacc.2004.06.070.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.